Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.
复制标题
DOI:
10.1007/s00262-011-1009-3
复制
发表时间:
2011-07
期刊:
影响因子:
--
通讯作者:
Riddell SR
中科院分区:
文献类型:
--
作者:
Anderson LD Jr;Cook DR;Yamamoto TN;Berger C;Maloney DG;Riddell SR
Multiple myeloma is incurable with standard therapies but is susceptible to a T-cell-mediated graft versus myeloma effect after allogeneic stem cell transplantation. We sought to identify myeloma-specific antigens that might be used for T-cell immunotherapy of myeloma. MAGE-C1 (CT-7) is a cancer-testis antigen that is expressed by tumor cells in >70% of myeloma patients and elicits a humoral response in up to 93% of patients with CT-7+ myeloma. No CD8+ T-cell epitopes have been described for CT-7, so we used a combination of reverse immunology and immunization of HLA-A2 transgenic mice with a novel cell-based vaccine to identify three immunogenic epitopes of CT-7 that are recognized by human CD8+ T-cells. CT-7-specific T-cells recognizing two of these peptides are able to recognize myeloma cells as well as CT-7 gene-transduced tumor cells, demonstrating that these epitopes are naturally processed and presented by tumor cells. This is the first report of the identification of immunogenic CD8+ T-cell epitopes of MAGE-C1 (CT-7), which is the most commonly expressed cancer-testis antigen found in myeloma, and these epitopes may be promising candidate targets for vaccination or T-cell therapy of myeloma or other CT-7+ malignancies.
登录
查看更多内容
影响因子:
158.5
作者:
Bruno, Benedetto;Rotta, Marcello;Boccadoro, Mario
通讯作者:
Boccadoro, Mario
DOI:
10.1073/pnas.202491499
发表时间:
2002-10-01
影响因子:
11.1
作者:
Dhodapkar, MV;Krasovsky, J;Olson, K
通讯作者:
Olson, K
影响因子:
20.3
作者:
Bensinger, WI;Buckner, CD;Appelbaum, FR
通讯作者:
Appelbaum, FR
影响因子:
20.3
作者:
Berger, C;Flowers, ME;Riddell, SR
通讯作者:
Riddell, SR
影响因子:
15.3
作者:
Dhodapkar, KM;Krasovsky, J;Dhodapkar, MV
通讯作者:
Dhodapkar, MV